Dow futures under pressure as Wall Street awaits FDA vaccine, ECB decision

U.S. stock-index futures tilt lower Thursday, ahead of weekly jobless benefit claims data, a decision by Food and Drug Administration on a vaccine approval, and further talks in Washington on another financial aid package to combat the impact of the coronavirus pandemic.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.